Mizuho Securities USA’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.03M Buy
558,486
+498,388
+829% +$5.41M 0.1% 187
2026
Q1
$649K Sell
60,098
-259,811
-81% -$2.8M 0.02% 614
2025
Q4
$3.38M Buy
319,909
+119,909
+60% +$1.28M 0.06% 291
2025
Q3
$2.1M Sell
200,000
-107,200
-35% -$1.13M 0.04% 403
2025
Q2
$3.21M Buy
307,200
+277,200
+924% +$2.9M 0.07% 280
2025
Q1
$303K Buy
+30,000
New +$307K 0.01% 613

Other funds holding GPAT

Mizuho Securities USA's GPAT Position: Q2 2026 in Review

Mizuho Securities USA increased its GP-Act III Acquisition Corp (GPAT) stake by 829% in Q2 2026, buying an estimated $5.41M and bringing the position to 558,486 shares worth $6.03M. The position accounts for 0.1% of the portfolio, ranked #187.

Mizuho Securities USA first reported a position in GPAT in Q1 2025 and has held it in 6 quarters since. 4 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • Mizuho Securities USA held 558,486 shares of GP-Act III Acquisition Corp worth $6.03M as of Q2 2026.
  • Mizuho Securities USA bought 498,388 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $5.41M.
  • GP-Act III Acquisition Corp made up 0.1% of Mizuho Securities USA's portfolio in Q2 2026, its #187 holding.
  • Mizuho Securities USA first reported a position in GP-Act III Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • 4 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.